Skip to content

MYGN - MYRIAD GENETICS INC - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchM

Myriad Genetics Inc

MYGN · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

M

MYGNMyriad Genetics Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 20

52-wk high: $8.59
52-wk low: $2.74
Prev close: $5.84
Mkt cap: $305.1M
Fwd P/E: 54.0x
Beta: 1.64

Smart money

8 funds hold a position and insiders have been net buying.

Real smart money

Funds holding this stock

8 holders

Combined position$213.2M

MI
Millennium
Israel Englander · Q2 2026 13F
$37.8M
position
DS
D.E. Shaw

Earnings

Reported Jul 30, 2026

Earnings came in $0.25 a share below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -41.3%
Forward P/E: 54.05
Market cap: $305M

Valuation

P/S0.55
P/B0.91

Quality

Operating margin-21.4%

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: MYGN
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
Market cap: $305.12M
Beta: 1.64

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/S

0.5x

P/B

0.9x

Profit margin

-41.3%

Op margin

-21.4%

ROE

-23.5%

Q2 2026 13F

$26.2M

position

GC

Glenview Capital

Larry Robbins · Q1 2026 13F

$24.4M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for MYGN

No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.33-$0.25

-$0.08 expected

Next report

What the street expects next

ROE

-23.5%

ROA-7.6%

Growth

Beta1.64